drugset / Trial / NCT00918606

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

NCT00918606 ↗

Phase 1 Completed 30 enrolled Neothetics, Inc
NaSingle-groupOpen-labelTreatment

Summary

An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.

Timeline

Start
2009-02
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LIPO-102 Unknown — —

Indications